Clinical Trial Update: Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]

View source ↗

Summary

Clinical trial update on adding paricalcitol to chemotherapy for previously untreated metastatic pancreatic ductal adenocarcinoma; the Phase 2 study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Paricalcitol (Zemplar) (paricalcitol)

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED